Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15192109rdf:typepubmed:Citationlld:pubmed
pubmed-article:15192109lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:15192109lifeskim:mentionsumls-concept:C0908604lld:lifeskim
pubmed-article:15192109lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:15192109lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:15192109lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15192109lifeskim:mentionsumls-concept:C1705810lld:lifeskim
pubmed-article:15192109lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:15192109lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:15192109pubmed:issue33lld:pubmed
pubmed-article:15192109pubmed:dateCreated2004-8-9lld:pubmed
pubmed-article:15192109pubmed:abstractTextWe show herein that removal of the first 86 amino acids (aa) of the N terminus (designated N) of type VI adenylyl cyclase (ACVI) caused the resultant ACVI mutant (ACVI-DeltaA87) to be more greatly inhibited by a Galpha(i)-coupled receptor or activated Galpha(i) protein. Moreover, in vitro binding of the full-length N and C1a domain (designated C1a), which interacts with Galpha(i), was detected. A truncated N terminus (aa 1-86) also interacted with C1a, suggesting that the C1a-interacting region is located within aa 1-86. Mutation analyses further revealed that N might interact with C1a in the region (aa 434-505) where Galpha(i) is bound. Mutations of two residues (Leu-472 and Val-476) located in this N-binding region of C1a suppressed the interaction between recombinant N and C1a and markedly reduced Galpha(i)-mediated inhibition of ACVI-DeltaA87. Further biochemical analyses of the effect of internal mutations of Leu-472/Val-476 on Galpha(i)-mediated inhibition of wild-type ACVI and ACVI-DeltaA87 suggested that N modulates the Galpha(i)-mediated inhibition of ACVI via binding to C1a when the level of Galpha(i) is low (i.e. around the IC(50) value) and that a more complicated interfering mode results when the level of Galpha(i) is high (i.e. approximately 10- to 20-fold of the IC(50) value). Collectively, data presented herein suggest a novel function of the N terminus of ACVI in Galpha(i)-mediated regulation.lld:pubmed
pubmed-article:15192109pubmed:languageenglld:pubmed
pubmed-article:15192109pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:citationSubsetIMlld:pubmed
pubmed-article:15192109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15192109pubmed:statusMEDLINElld:pubmed
pubmed-article:15192109pubmed:monthAuglld:pubmed
pubmed-article:15192109pubmed:issn0021-9258lld:pubmed
pubmed-article:15192109pubmed:authorpubmed-author:LaiHsing-LinH...lld:pubmed
pubmed-article:15192109pubmed:authorpubmed-author:KaoYu-YaYYlld:pubmed
pubmed-article:15192109pubmed:authorpubmed-author:HwangMing-Jin...lld:pubmed
pubmed-article:15192109pubmed:authorpubmed-author:ChernYijuangYlld:pubmed
pubmed-article:15192109pubmed:issnTypePrintlld:pubmed
pubmed-article:15192109pubmed:day13lld:pubmed
pubmed-article:15192109pubmed:volume279lld:pubmed
pubmed-article:15192109pubmed:ownerNLMlld:pubmed
pubmed-article:15192109pubmed:authorsCompleteYlld:pubmed
pubmed-article:15192109pubmed:pagination34440-8lld:pubmed
pubmed-article:15192109pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:meshHeadingpubmed-meshheading:15192109...lld:pubmed
pubmed-article:15192109pubmed:year2004lld:pubmed
pubmed-article:15192109pubmed:articleTitleAn important functional role of the N terminus domain of type VI adenylyl cyclase in Galphai-mediated inhibition.lld:pubmed
pubmed-article:15192109pubmed:affiliationInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, ROC.lld:pubmed
pubmed-article:15192109pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15192109pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:25289entrezgene:pubmedpubmed-article:15192109lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15192109lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15192109lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15192109lld:pubmed